Octet® R8e BLI System
High-performance label-free, real-time biomolecular analysis
Receive your quote directly from the manufacturer.
The Octet® R8e BLI System is the latest innovation in label-free, real-time biomolecular analysis, offering the most advanced detection capabilities in biolayer interferometry (BLI) technology. Designed to support complex workflows in drug discovery, process development, and GxP environments, the Octet® R8e delivers superior sensitivity, flexible assay design, and longer run times. Complete with 21 CFR Part 11 compliance solutions, enhanced BLI achieves new heights of sensitivity with a higher degree of flexibility, facilitating straightforward and confident data-driven decision-making also in regulated environments.
- Exceptional sensitivity: Improved signal-to-noise delivers precise, actionable insights, allowing for fast, accurate data collection even on low-molecular weight and low-concentration analytes.
- Flexible throughput: Compatibility with 96-well and 384-well microplates enables highly parallel processing in volumes as low as 40 μL.
- Extended walk-away operation: New evaporation control protects sample quality during long runtimes of up to 16 hours, maximizing productivity and reducing hands-on time.
- Versatility and compliance support: Easy assay transferability across the platform, along with 21 CFR Part 11 compliance options, ensures adherence to the rigorous standards of regulated environments.
Enhanced BLI analytics with new heights of sensitivity
Explore Sartorius’ most advanced biolayer interferometry (BLI) solution, designed for high-throughput, real-time biomolecular interaction analysis. The Octet® R8e delivers best-in-class sensitivity, enabling accurate detection of low molecular weight and low-abundance analytes. With features like 384-well plate compatibility, reduced sample volume (as low as 40 µL), extended unattended runtime (up to 16 hours), and intuitive software for streamlined workflows, this system empowers researchers to achieve reliable results faster and more efficiently. Ideal for applications across drug discovery, biologics development, and manufacturing.
Unveiling hidden insights: Enhanced analytics with new heights of sensitivity
This application note explores how the Octet® R8e system from Sartorius delivers next-level sensitivity and precision in real-time, label-free biomolecular interaction analysis. Learn how enhanced data acquisition, 384-well plate compatibility, and evaporation control enable accurate detection of low-concentration analytes and small molecules. Ideal for drug discovery, development, and bioprocessing, the Octet® R8e empowers researchers to streamline workflows, reduce costs, and uncover previously hidden molecular interactions.
How Sartorius is advancing global health through innovation
With 155 years of industry experience, innovation is in Sartorius' DNA. In this interview, Dr. Alexandra Gatzemeyer, Head of the LPS Division and Executive Board Member at Sartorius, highlights the importance of the company's latest technology releases. She explains how these advancements align with emerging trends in research and therapeutics and describes what a successful partnership with Sartorius looks like in practice.
This video was filmed at SLAS Europe 2025.
Enhanced BLI analytics accelerate your drug research, development, and manufacturing
Introducing the new Octet® R8e BLI System, the latest and most advanced biolayer interferometry (BLI) system for label-free, real-time biomolecular interaction analysis. In this interview, Deirdre Raduns, Octet® Product Manager at Sartorius, shares how enhanced BLI analytics achieve new heights of sensitivity, empowering users with exceptional sensitivity, extended run times, flexible assay design, and seamless compliance with 21 CFR Part 11. Discover how Octet® BLI boosts flexibility, throughput, and automation to streamline complex workflows in drug discovery, process development, and quality control under GxP regulations.
This video was filmed at SLAS Europe 2025.
